Albert's chemistry-native AI for R&D draws $55M Series B led by TCV
The Oakland company said the $55M will expand its chemistry-native AI capabilities, shortening development cycles and reducing time to market for everyday products.
Albert, an Oakland, California-based company that has built a chemistry-native AI operating system for research and development, has raised $55M in a Series B round.
TCV led the round. New investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion VC joined, alongside existing backers Coatue, J.P. Morgan Growth Equity Partners, Index Ventures, and Applied Ventures, LLC.
The company's premise is that materials discovery still runs on fragmented, manual workflows. Albert embeds chemistry-native AI in an operating system that captures experiments, structures data, and gives scientists a way to accelerate discovery. Built by chemists, the company says it helps organizations turn their R&D into a strategic advantage.
The new funding is earmarked for expanding Albert's chemistry-native AI capabilities, with the stated goal of shortening development cycles and reducing time to market for the everyday products used by billions of people.
The round blends a new lead in TCV with a returning investor group that spans growth equity and strategic backers. Applied Ventures, LLC, the venture arm associated with a materials-intensive industrial parent, remains on the cap table, as do Coatue, J.P. Morgan Growth Equity Partners, and Index Ventures — a mix that suggests the company is courting both financial and industrial capital as it scales.
Albert announced the round on October 14, 2026. The company did not disclose its valuation, revenue, or headcount in the announcement.
About the Company
built the first chemistry-native AI operating system for R&D